Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45219, United States.
Schizophr Res. 2011 Jun;129(1):57-65. doi: 10.1016/j.schres.2011.03.006. Epub 2011 Mar 31.
Polyunsaturated fatty acids (PUFA), a lipid family comprised of omega-3 (n-3) and n-6 fatty acids, are a critical component of cellular membranes, and recent in vitro studies have found that antipsychotic medications up-regulate genes responsible for PUFA biosynthesis. To evaluate this effect in vivo, rats were treated with risperidone (1.5, 3, 6mg/kg/day), paliperidone (1.5, 3, 6mg/kg/day), olanzapine (2.5, 5, 10mg/kg/day), quetiapine (5, 10, 20mg/kg/day), haloperidol (1, 3mg/kg/day) or vehicle through their drinking water for 40day. Effects on liver Fads1, Fads2, Elovl2, and Elovl5 mRNA expression, plasma indices of n-3 (plasma 22:6/18:3 and 20:5/18:3 ratios) and n-6 (plasma 20:4/18:2 and 20:3/18:2 ratios) biosynthesis, and peripheral (erythrocyte, heart) and central (frontal cortex) membrane PUFA composition were determined. Only risperidone and its metabolite paliperidone significantly and selectively up-regulated liver delta-6 desaturase (Fads2) mRNA expression, and robustly increased plasma indices of n-3 and n-6 fatty acid biosynthesis. In risperidone- and paliperidone-treated rats, plasma indices of n-3 and n-6 fatty acid biosynthesis were all positively correlated with liver Fads2 mRNA expression, but not Fads1, Elovl2, or Elovl5 mRNA expression. All antipsychotics at specific doses increased erythrocyte docosahexaenoic acid (DHA, 22:6n-3) composition, and all except quetiapine increased arachidonic acid (AA, 20:4n-6) composition. Risperidone, paliperidone, and olanzapine increased heart DHA and AA composition, and no antipsychotic altered frontal cortex DHA or AA composition. These in vivo data demonstrate that augmentation of PUFA biosynthesis is not common to all antipsychotic medications, and that risperidone and paliperidone uniquely increase delta-6 desaturase (Fads2) mRNA expression and most robustly increase PUFA biosynthesis and peripheral membrane composition.
多不饱和脂肪酸(PUFA)是一类脂质家族,由ω-3(n-3)和 n-6 脂肪酸组成,是细胞膜的重要组成部分。最近的体外研究发现,抗精神病药物上调了负责 PUFA 生物合成的基因。为了在体内评估这种作用,将大鼠用利培酮(1.5、3、6mg/kg/天)、帕利哌酮(1.5、3、6mg/kg/天)、奥氮平(2.5、5、10mg/kg/天)、喹硫平(5、10、20mg/kg/天)、氟哌啶醇(1、3mg/kg/天)或载体通过饮用水处理 40 天。测定了肝脏 Fads1、Fads2、Elovl2 和 Elovl5 mRNA 表达、血浆 n-3(血浆 22:6/18:3 和 20:5/18:3 比值)和 n-6(血浆 20:4/18:2 和 20:3/18:2 比值)生物合成的血浆指数,以及外周(红细胞、心脏)和中枢(额叶皮层)膜 PUFA 组成。只有利培酮及其代谢物帕利哌酮显著且选择性地上调了肝脏 δ-6 去饱和酶(Fads2)mRNA 表达,并强烈增加了 n-3 和 n-6 脂肪酸生物合成的血浆指数。在利培酮和帕利哌酮处理的大鼠中,n-3 和 n-6 脂肪酸生物合成的血浆指数均与肝脏 Fads2 mRNA 表达呈正相关,但与 Fads1、Elovl2 或 Elovl5 mRNA 表达无关。所有抗精神病药物在特定剂量下均增加了红细胞二十二碳六烯酸(DHA,22:6n-3)组成,除了喹硫平之外,所有药物均增加了花生四烯酸(AA,20:4n-6)组成。利培酮、帕利哌酮和奥氮平增加了心脏 DHA 和 AA 组成,没有抗精神病药物改变了额叶皮层 DHA 或 AA 组成。这些体内数据表明,PUFA 生物合成的增加并非所有抗精神病药物所共有,利培酮和帕利哌酮独特地增加了 δ-6 去饱和酶(Fads2)mRNA 表达,并最强烈地增加了 PUFA 生物合成和外周膜组成。